Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003272849> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W2003272849 endingPage "166" @default.
- W2003272849 startingPage "162" @default.
- W2003272849 abstract "Forty-eight patients with hematologic malignancies treated by allogeneic marrow transplantation developed acute graft-versus-host disease (GVHD), grades II-IV, despite prophylaxis with methotrexate. They were treated with a combination of antithymocyte globulin (ATG) and cyclosporine (CsA), with or without the addition of methylprednisolone (MP). Thirty patients had received HLA-identical and 18 HLA-nonidentical transplants. Median onset of GVHD was day 13 (range 8–60) for patients with HLA-nonidentical grafts and day 18 (range 7–48) for patients given HLA-identical grafts (P = 0.01). Forty-five patients could be evaluated for response on day 7 of therapy. Among these, 13 of 27 given ATG/CSP and 6 of 18 given ATG/CSP/MP improved. Among 33 patients evaluable on day 14 of therapy 13 of 19 given ATG/CSP and 5 of 14 given ATG/CSP/MP showed improvement of GVHD. Patients given HLA-nonidentical grafts responded somewhat (although not significantly) less frequently than patients given HLA-identical grafts. Chronic GVHD developed in 16 of 18 evaluable patients given ATG/CSP and in 5 of 6 given ATG/CSP/MP. Survival beyond 6 months was 67% among patients treated with ATG/CSP and 25% with ATG/CSP/MP. These data indicate that a regimen of ATG/CSP is of value in the treatment of acute GVHD. The addition of MP was not beneficial and resulted in decreased survival—presumably because of excessive immunosuppression and associated complications." @default.
- W2003272849 created "2016-06-24" @default.
- W2003272849 creator A5003452358 @default.
- W2003272849 creator A5037247107 @default.
- W2003272849 creator A5050154369 @default.
- W2003272849 creator A5050374901 @default.
- W2003272849 creator A5053986124 @default.
- W2003272849 creator A5056405520 @default.
- W2003272849 creator A5085787488 @default.
- W2003272849 creator A5089314070 @default.
- W2003272849 date "1985-08-01" @default.
- W2003272849 modified "2023-10-01" @default.
- W2003272849 title "TREATMENT OF HUMAN ACUTE GRAFT-VERSUS-HOST DISEASE WITH ANTITHYMOCYTE GLOBULIN AND CYCLOSPORINE WITH OR WITHOUT METHYLPREDNISOLONE" @default.
- W2003272849 doi "https://doi.org/10.1097/00007890-198508000-00011" @default.
- W2003272849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3895622" @default.
- W2003272849 hasPublicationYear "1985" @default.
- W2003272849 type Work @default.
- W2003272849 sameAs 2003272849 @default.
- W2003272849 citedByCount "76" @default.
- W2003272849 countsByYear W20032728492012 @default.
- W2003272849 countsByYear W20032728492013 @default.
- W2003272849 countsByYear W20032728492020 @default.
- W2003272849 countsByYear W20032728492021 @default.
- W2003272849 crossrefType "journal-article" @default.
- W2003272849 hasAuthorship W2003272849A5003452358 @default.
- W2003272849 hasAuthorship W2003272849A5037247107 @default.
- W2003272849 hasAuthorship W2003272849A5050154369 @default.
- W2003272849 hasAuthorship W2003272849A5050374901 @default.
- W2003272849 hasAuthorship W2003272849A5053986124 @default.
- W2003272849 hasAuthorship W2003272849A5056405520 @default.
- W2003272849 hasAuthorship W2003272849A5085787488 @default.
- W2003272849 hasAuthorship W2003272849A5089314070 @default.
- W2003272849 hasBestOaLocation W20032728491 @default.
- W2003272849 hasConcept C126322002 @default.
- W2003272849 hasConcept C141071460 @default.
- W2003272849 hasConcept C147483822 @default.
- W2003272849 hasConcept C188280979 @default.
- W2003272849 hasConcept C203014093 @default.
- W2003272849 hasConcept C2779972918 @default.
- W2003272849 hasConcept C2780252810 @default.
- W2003272849 hasConcept C2780372218 @default.
- W2003272849 hasConcept C2780882860 @default.
- W2003272849 hasConcept C2781059491 @default.
- W2003272849 hasConcept C2781413609 @default.
- W2003272849 hasConcept C2911091166 @default.
- W2003272849 hasConcept C71924100 @default.
- W2003272849 hasConcept C81358767 @default.
- W2003272849 hasConcept C90924648 @default.
- W2003272849 hasConceptScore W2003272849C126322002 @default.
- W2003272849 hasConceptScore W2003272849C141071460 @default.
- W2003272849 hasConceptScore W2003272849C147483822 @default.
- W2003272849 hasConceptScore W2003272849C188280979 @default.
- W2003272849 hasConceptScore W2003272849C203014093 @default.
- W2003272849 hasConceptScore W2003272849C2779972918 @default.
- W2003272849 hasConceptScore W2003272849C2780252810 @default.
- W2003272849 hasConceptScore W2003272849C2780372218 @default.
- W2003272849 hasConceptScore W2003272849C2780882860 @default.
- W2003272849 hasConceptScore W2003272849C2781059491 @default.
- W2003272849 hasConceptScore W2003272849C2781413609 @default.
- W2003272849 hasConceptScore W2003272849C2911091166 @default.
- W2003272849 hasConceptScore W2003272849C71924100 @default.
- W2003272849 hasConceptScore W2003272849C81358767 @default.
- W2003272849 hasConceptScore W2003272849C90924648 @default.
- W2003272849 hasIssue "2" @default.
- W2003272849 hasLocation W20032728491 @default.
- W2003272849 hasLocation W20032728492 @default.
- W2003272849 hasLocation W20032728493 @default.
- W2003272849 hasOpenAccess W2003272849 @default.
- W2003272849 hasPrimaryLocation W20032728491 @default.
- W2003272849 hasRelatedWork W1561021268 @default.
- W2003272849 hasRelatedWork W1986974915 @default.
- W2003272849 hasRelatedWork W2061745056 @default.
- W2003272849 hasRelatedWork W2179520038 @default.
- W2003272849 hasRelatedWork W2400622957 @default.
- W2003272849 hasRelatedWork W2427765071 @default.
- W2003272849 hasRelatedWork W2517655662 @default.
- W2003272849 hasRelatedWork W2610797946 @default.
- W2003272849 hasRelatedWork W2986071054 @default.
- W2003272849 hasRelatedWork W4247998951 @default.
- W2003272849 hasVolume "40" @default.
- W2003272849 isParatext "false" @default.
- W2003272849 isRetracted "false" @default.
- W2003272849 magId "2003272849" @default.
- W2003272849 workType "article" @default.